Searched for
NHS PATIENT DATA MANAGEMENT
UK reviewing Palantir's NHS contract amid pressure to use break clauseBritain is reviewing a major contract with American firm Palantir for the National Health Service. The government must decide by early 2027...- GSK in talks to buy cancer biotech Nuvalent for more than $9 billionBritish drug giant GSK is reportedly in talks to acquire cancer drugmaker Nuvalent. The deal could be worth over nine billion dollars. Disc...
- India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Elon Musk's biggest rival isn't a startup, it's China, and they just won the brain chip raceElon Musk brain chip Neuralink competitor: China has approved the world's first brain-computer chip, NEO, for commercial sale after complet...
- As Cos fast-track AI adoption, data & infra readiness come under spotlightPriorities for next phase: Real-time decision-making, customer experience, sovereign control over data, and compliance.
- Asset allocation in 2026: Gold and silver outperform as equities struggle amid market volatilityWelcome to TrendMap, your quick, visual guide to the performance of different investment segments. In this edition, we present a 10-year pe...
- As cos fast-track AI adoption, data & infra readiness come under spotlightIndian companies are rapidly adopting artificial intelligence. While some have fully integrated AI, many are still in pilot phases. Challen...
- Data centre developer Switch in talks to raise funds at $50 billion-plus valuation: ReportBrookfield Asset Management, KKR and other private equity and institutional investors have been in talks to invest in the round, the repor...
- Delhi hotel fire toll rises to 21; 19 remain critical, including 10 foreigners on ventilatorsA devastating fire at the Flourish Stay B&B in Malviya Nagar has claimed 21 lives, including 11 foreign nationals and 10 Indians. The blaze...
- UK urged to end contract with US AI-firm PalantirBritish lawmakers called Wednesday for the government to end a contract between the country's National Health Service and AI giant Palantir...
- US services activity heats up in May, beating expectations: SurveyUS services sector activity expanded in May, exceeding expectations with the ISM index at 54.5%. While business activity and new orders gre...
- Indian market at 11% discount to long-term average; Anshul Saigal says it's a buyer's market for 3–5 year investorsMarket confusion presents a rare chance for patient investors. Anshul Saigal believes current valuations offer significant gains for those ...
- Zydus Semaglutide approval: Delhi HC directs CDSCO to decide on patient safety concernsThe Delhi High Court has asked the Central Drugs Standard Control Organisation to review a petition challenging Zydus Lifesciences' approva...
- AI-Powered drug discovery could transform treatment development for Alzheimer’s, Parkinson’s and other brain disorders.Researchers are increasingly using AI to accelerate the search for treatments for neurological conditions such as Alzheimer’s, Parkinson’s,...
- Good news for diabetes & BP patients: Govt cuts prices of these 30 medicines, relief may reach pharmacies soonThe National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 30 essential drug formulations, including those for diabet...
- Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- GSK's chronic hepatitis B drug helps one in five achieve functional cure in key studiesGSK's experimental hepatitis B drug, bepirovirsen, showed promising results in late-stage studies, with nearly one in five patients achievi...
- Gene therapy for cholesterol: Initial test results cheerA new gene editing medicine, VERVE-102, offers hope for millions with heart conditions. Eli Lilly's drug showed significant reductions in b...
Load More
